Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actos Tablets special drug use surveillance in metabolic syndrome with type 2 diabetes mellitus
jRCT1080222279
- Sponsor
- Takeda
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of pioglitazone in type 2 diabetes mellitus (T2DM) and cardiometabolic risk (CMR), sponsored by Takeda.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)cardiometabolic risk (CMR)
Beyond the preview
Go deeper on jRCT1080222279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222279.